Data / Form D filings / Aadi Bioscience, Inc.
Aadi Bioscience, Inc.: Form D filings
Aadi Bioscience, Inc., a biotechnology company in Morristown, NJ, filed 5 Form D notices with the SEC between 2017 and 2025. The latest, on March 18, 2025, reports $100 million sold of a $100 million offering to 17 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2 HEADQUARTERS PLAZA, EAST BUILDING, 11TH FLOOR, Morristown, NJ, 07960
- Phone
- (551) 321-2234
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1422142
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 18, 2025 | New notice | $100,002,392 | $100,002,392 | 17 | Mar 4, 2025 | sec.gov | |
| Oct 11, 2022 | New notice | $72,500,000 | $72,499,995 | $5 | 13 | Sep 26, 2022 | sec.gov |
| Sep 10, 2021 | New notice | $155,000,000 | $154,999,876 | $124 | 31 | Aug 26, 2021 | sec.gov |
| Sep 10, 2021 | New notice | $82,500,000 | $82,500,000 | 15 | Aug 26, 2021 | sec.gov | |
| Mar 30, 2017 | New notice | $41,835,597 | $41,835,597 | 264 | Mar 15, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Baiteng Zhao | Director | |
| Scott Giacobello | Executive Officer | |
| Caley Castelein | Director | |
| Richard Maroun | Director | |
| Bryan Ball | Executive Officer | |
| Behzad Aghazadeh | Director | |
| Emma Reeve | Director | |
| Dave Lennon | Executive Officer, Director | |
| David Dornan | Executive Officer | |
| Mohammad Hirmand | Director | |
| Karin Hehenberger | Director | |
| Neil Desai | Director | |
| Anupam Dalal | Director |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
- Bullseye Biodevices, Inc. $1.3 million · Aug 10, 2026
- Hepion Pharmaceuticals, Inc. $3.1 million · Aug 5, 2026
Every Form D from the week of Mar 17, 2025 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Aadi Bioscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.